Opinion | Should There Be Limits to Research on Human Embryos? The New York Times
Opinion | Should There Be Limits to Research on Human Embryos? The New York Times
In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma Nature.com
Mesenchymal stem cells-derived small extracellular vesicles and apoptotic extracellular vesicles for wound healing and skin regeneration: a systematic review and meta-analysis of preclinical studies Journal of Translational Medicine
7-year-old Camp Hill boy with severe health issues proves nothing is impossible | Health Smart WPMT FOX 43
The big picture: Nearly two decades ago, Shinya Yamanaka and Kazutoshi Takahashi discovered they could turn mature somatic cells back into stem cells. The scientists predicted these new cells could be the key to regenerative treatments for serious injuries and conditions. Today, another Japanese team has achieved the first promising results of this breakthrough. Researchers at Keio University have begun using induced pluripotent stem cells (iPS) to treat and maybe even cure severe spinal cord injuries. The iPS technology was first conceived by Shinya Yamanaka in 2006, who later received the Nobel Prize with John Gurdon for discovering that they could reprogram adult cells to return to their pluripotent, stem cell-like state.
'Stem cell treatment helped improve spinal cord injuries' New Vision
Adia Med Explores International Expansion Following Global Interest in Its Innovative Umbilical Cord Blood Stem Cell Therapies Newsfile
Reality hits: hard truths come to light in the final episode of Lost Cells SWI swissinfo.ch in English
View original post here: Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
Link: Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
Recent Comments